Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Hayakawa K, Matsumura Y, Uemura K, Tsuzuki S, Sakurai A, Tanizaki R, Shinohara K, Hashimoto T, Hase R, Matono T, Kato H, Mawatari M, Hara H, Hamada Y, Saito S, Ohmagari N, Doi Y. Hayakawa K, et al. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0051023. doi: 10.1128/aac.00510-23. Epub 2023 Sep 13. Antimicrob Agents Chemother. 2023. PMID: 37702483 Free PMC article.
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Hayakawa K, Miyoshi-Akiyama T, Kirikae T, Nagamatsu M, Shimada K, Mezaki K, Sugiki Y, Kuroda E, Kubota S, Takeshita N, Kutsuna S, Tojo M, Ohmagari N. Hayakawa K, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3441-50. doi: 10.1128/AAC.02652-13. Epub 2014 Apr 7. Antimicrob Agents Chemother. 2014. PMID: 24709261 Free PMC article.
Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S. Sherchan JB, et al. Among authors: hayakawa k. Antimicrob Agents Chemother. 2015;59(6):3424-32. doi: 10.1128/AAC.00270-15. Epub 2015 Mar 30. Antimicrob Agents Chemother. 2015. PMID: 25824221 Free PMC article.
Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N. Hayakawa K, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):697-708. doi: 10.1093/jac/dkz501. J Antimicrob Chemother. 2020. PMID: 31789374
A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan.
Saito S, Hayakawa K, Tsuzuki S, Ishikane M, Nagashima M, Mezaki K, Sugiki Y, Tajima T, Matsunaga N, Ide S, Kinoshita N, Kusama Y, Fujitomo Y, Nakamoto T, Toda Y, Kaku M, Kodama EN, Ohmagari N. Saito S, et al. Among authors: hayakawa k. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01483-20. doi: 10.1128/AAC.01483-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33257451 Free PMC article.
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function.
Hamada Y, Kasai H, Suzuki-Ito M, Matsumura Y, Doi Y, Hayakawa K. Hamada Y, et al. Among authors: hayakawa k. Antibiotics (Basel). 2022 Mar 28;11(4):456. doi: 10.3390/antibiotics11040456. Antibiotics (Basel). 2022. PMID: 35453208 Free PMC article.
2,127 results